Status:
COMPLETED
ICU Readmission in Adult Egyptian Patients Undergoing Living Donor Liver Transplant
Lead Sponsor:
Ain Shams University
Conditions:
ICU Readmission
Eligibility:
All Genders
18+ years
Brief Summary
Liver transplantation is the only definitive treatment for end stage liver disease. Being a major abdominal surgery, may have postoperative complications that require readmission, which may be serious...
Detailed Description
* This retrospective observational study will be conducted in Ain Shams University Specialized Hospital on 335 adult (age ≥18 years) Egyptian patients undergoing living donor liver transplant (LDLT) b...
Eligibility Criteria
Inclusion
- Adult Egyptian Patients \>18 years
Exclusion
- Patient refusal.
- Patients who were not discharged after LDLT due to death.
- Patients who underwent re-transplantation before discharge from the ICU after the first liver transplant.
- Pregnancy.
Key Trial Info
Start Date :
October 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2021
Estimated Enrollment :
299 Patients enrolled
Trial Details
Trial ID
NCT04067739
Start Date
October 15 2019
End Date
June 20 2021
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanaa El Gendy
Cairo, Ain Shams University Specialized Hospital, Egypt